Clinical trial

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

University Health Network, TorontoActive, not recruitingPhase 2Started Jun 6, 202415 enrolledCanadaNCT06416085

Abstract

The PEARL Pilot is a phase II open-label trial. Participants will receive a single high-dose (25 mg) of psilocybin in the context of Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinPalliative care

Keywords

Advanced CancerAdvanced CancerStage IV Solid Tumor CancerStage IV Sarcoma of BoneStage IV LymphomaStage IV MelanomaEndocrine Cancer

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.